Source:http://linkedlifedata.com/resource/pubmed/id/10796671
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-7-6
|
pubmed:abstractText |
Typical antipsychotic drugs are widely used as first line treatment for people with schizophrenia. The atypical class of antipsychotic drugs, however, is making important inroads into this approach and zotepine is one such compound. It is a dopamine antagonist and claimed to be to be particularly effective for negative symptoms
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD001948
|
pubmed:dateRevised |
2007-1-19
|
pubmed:meshHeading | |
pubmed:year |
2000
|
pubmed:articleTitle |
Zotepine for schizophrenia.
|
pubmed:affiliation |
Trent Ward, South Tees Community and Mental Health Services Trust, St Lukes Hospital, Marton Road, Middlesborough, Cleveland, UK, TS4 3EE. rsmor@globalnet.co.uk
|
pubmed:publicationType |
Journal Article,
Review
|